Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
WORLD / Science & Health
Apr 29, 2021
Dark horse of vaccine race may be this French biotech
With the other COVID-19 vaccines in Europe focused on the virus's spike protein, this shot could protect against variants that might compromise others, making it the perfect booster.
Japan Times
WORLD
Apr 26, 2021
When it comes to a restart of global travel, all vaccines are not equal
A patchwork of approvals across the world is laying the groundwork for a global vaccine bifurcation, where the shot you get could determine which countries you can enter and work in.
Japan Times
WORLD
Apr 24, 2021
U.S. ends Johnson & Johnson COVID-19 vaccine pause, says shots to resume immediately
Officials found just 15 cases among the 8 million shots given that had experienced the syndrome involving severe blood clots and low platelets as a result of the vaccine.
Japan Times
ASIA PACIFIC
Apr 23, 2021
How South Korea stepped up specialty syringe production for COVID-19 vaccines
South Korea's relative abundance of low dead space syringes has helped it give 3.4% of its population at least one dose of a coronavirus vaccine, compared with 1.1% in Japan.
Japan Times
WORLD
Apr 22, 2021
U.S. weighs global vaccine intellectual property waiver opposed by drugmakers
The European Union, U.K., Japan, Switzerland, Brazil and Norway are also among territories resisting the measure currently before the WTO.
Japan Times
WORLD
Apr 21, 2021
How the WHO's push for global vaccines needled Europe
The EU's ambivalence stems partly from short supplies and a slack start to the COVAX program, but also from concerns that the EU's efforts will go unnoticed in a vaccine diplomacy war.
Japan Times
WORLD
Apr 18, 2021
COVID-19 survivors may need just one shot of a two-dose vaccine, studies show
The issue has become all the more urgent since safety concerns have been raised about vaccines from Johnson & Johnson and AstraZeneca.
Japan Times
WORLD / Science & Health
Apr 17, 2021
Why the vaccine safety numbers are still fuzzy
If there is a connection between the Johnson & Johnson vaccine and a rare clotting syndrome, new cases are likely to emerge now that the word is out.
Japan Times
ASIA PACIFIC
Apr 15, 2021
How China fell behind after passing up a vaccine opportunity
In the early stages of the pandemic, China and other Asian nations failed to jump on mRNA tech, which has become the breakout star of the COVID-19 era.
Japan Times
WORLD / Science & Health
Apr 14, 2021
Vaccine blood-clot side effect puts focus on immune reaction
Health officials are exploring whether and how an immune reaction may occur in people who have received vaccines made by AstraZeneca and Johnson & Johnson.
Japan Times
WORLD
Apr 13, 2021
U.S. calls for pause on Johnson & Johnson vaccine after clotting cases
The concerns about the shot mirror those about AstraZeneca's, which European regulators began investigating last month after some recipients developed blood clots.
Japan Times
ASIA PACIFIC
Apr 12, 2021
Asian nations scale back AstraZeneca rollout amid safety woes
The moves may delay protection for the region amid concerns that the shot could trigger a rare and potentially deadly blood clotting condition.
Japan Times
ASIA PACIFIC
Apr 12, 2021
China considering mixing COVID-19 vaccines to boost protection rate
The move comes after Beijing's top disease official said the country's available vaccines 'don't have very high rates of protection.'
Japan Times
JAPAN
Apr 10, 2021
Japanese drug regulator to fast-track any modified vaccines to fight variants
Vaccines targeting new variants of the coronavirus won't require domestic clinical trials if the production process and handling of the shots are similar to those of the original.
Japan Times
ASIA PACIFIC
Apr 2, 2021
One of Taiwan’s few allies weighs embracing China for vaccines
As poor nations struggle to get their hands on vaccines, a thinly-populated South American country finds its chances linked to its unexpected role in tensions between the U.S. and China.
Japan Times
WORLD
Mar 30, 2021
Pfizer and Moderna vaccines highly effective after first shot in real-world use, study finds
The results validate earlier studies that had indicated the vaccines begin to work soon after a first dose, and confirm that they also prevent asymptomatic infections.
Japan Times
WORLD / Science & Health
Mar 24, 2021
Manslaughter probes in Italy worsen AstraZeneca vaccine troubles
Two doctors and a nurse in Sicily were placed under investigation following the sudden death of a navy officer hours after he received the shot.
Japan Times
WORLD
Mar 24, 2021
AstraZeneca’s pain grows as U.S. questions beleaguered COVID-19 vaccine
U.S. trial data showing the firm's shot to be highly effective was a welcome reprieve this week, but the good news lasted less than a day.
Japan Times
JAPAN / Science & Health
Mar 23, 2021
Japanese firms launch domestic clinical trials for COVID-19 vaccines
Even as Daiichi Sankyo and KM Biologics begin work to prove their shots' efficacy and safety, the public is unlikely to have access to them until fiscal 2022 at the earliest.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?